Table of Contents
- Epidemiology of Bradycardia and Tachycardia in Children
- Etiology and Pathophysiology of Bradycardia and Tachycardia in Children
- Clinical Presentation of Bradycardia and Tachycardia in Children
- Diagnostic Workup for Bradycardia and Tachycardia in Children
- Treatment of Bradycardia and Tachycardia in Children
Bradycardia can be defined as a heart rate that is slower than the lower limit for a normal heart rate after accounting for the child’s age. Tachycardia is defined as a heart rate that is faster than the upper limit of a normal heart rate for the child’s age. Bradycardia can be due to depression of the sinus node or a block in the conduction system. Tachycardia can originate from the atria as seen in atrial ectopic beats, atrial flutter or atrial fibrillation, from the atrioventricular (AV) node or from the ventricles in the case of ventricular arrhythmias.
Epidemiology of Bradycardia and Tachycardia in Children
Cardiac arrhythmias are quite common in children with an estimated incidence of 55 per 100,000 children presenting to the emergency department. The most common form of cardiac arrhythmias in children is sinus tachycardia, followed by the collective disorders known as supraventricular tachycardia and finally bradycardia. Atrial fibrillation is rare in children.
Etiology and Pathophysiology of Bradycardia and Tachycardia in Children
The most common form of cardiac arrhythmias in children is sinus tachycardia. Sinus tachycardia can be caused by any febrile illness, can be a consequence to dehydration or can be related to respiratory distress. Atrial fibrillation in children can happen because of atrial dilatation. Atrial dilatation is a possible complication of large atrial septal defects, mitral valve stenosis, or mitral valve insufficiency.
Sinus bradycardia is most commonly caused by hypoxemia. Respiratory failure, inadequate oxygenation of the blood due to congenital heart disease or lung disease, and hypothermia are commonly associated with a depressed sinus node and sinus bradycardia. Metabolic acidosis is another common cause of bradycardia in children.
Patients with increased intracranial pressure due to tumors or other obstructive lesions can present with hypertension and bradycardia, a sign of impending brain tonsillar herniation.
Complete heart block can be an isolated disease in children or can be a complication of structural heart disorders. Cardiac surgery, for instance, catheter-alcohol ablation of the left ventricular wall in hypertrophic cardiomyopathy is a common cause of complete AV block. Maternal history of systemic lupus erythematosus or scleroderma has been also linked to an increased risk of complete heart block in the offspring. Hypothyroidism should be excluded in any child presenting with bradycardia due to AV block.
Infective endocarditis and viral myocarditis can be also associated with bradycardia but are more commonly associated with ventricular arrhythmias. Electrolyte disturbances such as hypocalcemia or hyperkalemia can also cause bradycardia.
The most common cause of ventricular arrhythmias is ventricular fibrosis and scarring. Ventricular fibrosis can be linked to hypertrophic cardiomyopathy or myocarditis in children. Postoperative ventricular tachycardia can happen as a complication of any heart surgery involving the ventricles. The most common mechanisms for ventricular arrhythmias are reentrant arrhythmia or automatic ventricular pacemakers such as seen in ventricular ectopic beats. Atrial arrhythmias are also caused by spontaneous depolarization and electrical automaticity of the myocardium.
Clinical Presentation of Bradycardia and Tachycardia in Children
Patients with bradycardia might be asymptomatic. The most common symptoms of bradycardia can be explained by decreased cardiac output and include presyncope and syncope, dizziness, confusion, and decreased exercise tolerance. Young children and infants with a complete heart block might present with congestive heart failure.
Patients with ventricular tachycardia or other ventricular arrhythmias usually complain of palpitations, presyncope, syncope, or dizziness and confusion. Respiratory distress is also commonly seen. Sudden cardiac death due to ventricular fibrillation can be the presenting feature of a ventricular arrhythmia especially in children with hypertrophic cardiomyopathy.
Patients who have an ongoing infection or a febrile illness might present with sinus tachycardia. Such patients will complain of palpitations, shortness of breath and other symptoms that are specific to the site of infection. Chest pain can be related to myocarditis and can be associated with ventricular arrhythmias.
The most common presenting feature of supraventricular tachycardia is palpitations followed by dizziness and shortness of breath. These arrhythmias are less likely to be associated with syncope.
Finally, patients who have atrial fibrillation might present with symptoms and signs suggestive of the embolic disease.
Diagnostic Workup for Bradycardia and Tachycardia in Children
The first step in the evaluation of a child presenting with palpitations is to perform an electrocardiogram. The electrocardiogram can help the treating physician in identifying the type of the arrhythmia, and the seriousness of the condition. At the same time, it is always advisable to check the child’s hemodynamic status.
Because of the association between myocyte damage and ventricular arrhythmias, it is recommended to check troponins levels in children presenting with frequent and symptomatic ventricular ectopic beats or ventricular tachycardia. A complete blood count is also indicated to exclude anemia, a common cause of sinus tachycardia, leukocytosis which is suggestive of an ongoing infection, and an elevated erythrocyte sedimentation rate which is linked to myocarditis or endocarditis.
Patients with a complete heart block should be evaluated for possible Lyme disease, should undergo a throat swab test and an anti-streptolysin O test to evaluate for a possible strep throat and rheumatic fever, and should be evaluated for possible infection with influenza or respiratory syncytial virus infection.
Patients should also undergo an echocardiography when myocarditis or endocarditis is suspected. Serum electrolytes should be checked. Hypocalcemia has been linked with ventricular arrhythmias and complete heart block. Hyper and hypokalemia are also associated with an increased risk of ventricular ectopic beats and ventricular tachycardia.
Thyroid function tests are indicated to exclude hypothyroidism, a common cause of bradycardia in children. Arterial blood gasses should be assessed because acidosis and hypoxemia have been both linked with bradycardia.
Patients who complain of palpitations but are found to have a normal electrocardiogram might need Holter monitoring. Holter monitoring makes it possible to identify the type of the arrhythmia the child might have.
Finally, cardiac electrophysiology studies are indicated to evaluate the heart for possible abnormal conduction pathways, and automatic ectopic ventricular or atrial paces.
Treatment of Bradycardia and Tachycardia in Children
Asymptomatic children with bradycardia should be monitored closely and the cause of the bradycardia should be corrected. For instance, if the child has acidosis, the cause of acidosis needs to be determined and promptly corrected. Symptomatic patients, on the other hand, should be treated with atropine or isoproterenol. These drugs should be used temporarily in children with a complete heart block until a permanent pacemaker is implanted.
When the cause of bradycardia is obvious such as hypothyroidism or an electrolyte imbalance, correction of the cause can also be adequate in the treatment of the bradycardia.
Patients with ventricular arrhythmias should be started on verapamil or diltiazem especially if the cause of the arrhythmia can be attributed to hypertrophic cardiomyopathy. Amiodarone can be also used for the treatment of ventricular arrhythmias in children. It should be noted that the pharmacological treatment of ventricular arrhythmias in children has not be associated with a decreased mortality rate.
Patients with recurrent ventricular tachycardia and hypertrophic cardiomyopathy might be candidates for the implantation of an implantable cardioverter-defibrillator. The use of these devices has been proved to be lifesaving in children with hypertrophic cardiomyopathy and has been linked to a decreased risk of sudden cardiac death.
Children who have sinus tachycardia due to dehydration or a febrile illness usually respond well to the treatment of the etiology. For instance, the use of adequate analgesia and antibiotic therapy for an infectious etiology is known to bring down the fever in the child which in turn might correct the sinus tachycardia.
Patients who have frequent atrial arrhythmias or supraventricular tachycardia should be evaluated for possible automaticity of the atria and myocardium. Ablation of the automatic focus might be curative in some patients. Beta-blockers and calcium channel blockers can be also used in the treatment of supraventricular tachycardia but care must be taken to exclude Wolf-Parkinson-White syndrome before the administration of calcium channel blockers such as verapamil. Verapamil has a selective effect on the AV node.
By slowing conduction at the AV node in patients with an accessory atrioventricular pathway, conductance is usually improved in the accessory pathway. This can explain the increased risk of ventricular arrhythmias after the use of calcium channel blocks in patients with atrial fibrillation and Wolf-Parkinson-White syndrome.
Finally, patients with atrial fibrillation should receive digoxin, diuretics, and beta-blockers or calcium channel blockers. Additionally, anticoagulation therapy might be needed to prevent the formation of intramural thrombi within the atria.